Edition:
India

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

28.95INR
10:23am IST
Change (% chg)

Rs-0.40 (-1.36%)
Prev Close
Rs29.35
Open
Rs29.40
Day's High
Rs29.50
Day's Low
Rs28.55
Volume
684,089
Avg. Vol
2,212,815
52-wk High
Rs52.30
52-wk Low
Rs23.55

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 1,993.94 -0.168
Dec 2,184.34 0.410
Sep 2,738.09 0.230
Jun 2,210.56 0.333
FY 2017 Mar '17 1,847.49 -0.152
Dec 2,152.39 0.243
Sep 1,804.26 0.017
Jun 1,867.47 0.110
FY 2016 Mar '16 2,102.31 -0.140
Dec 2,174.07 0.440
Sep 2,555.30 0.852
Jun 2,101.59 0.769
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 2,320.50 2,393.00 2,248.00 --
Year Ending Mar-18 1 9,520.00 9,520.00 9,520.00 --
Year Ending Mar-19 1 10,893.00 10,893.00 10,893.00 11,705.50
Year Ending Mar-20 1 13,155.00 13,155.00 13,155.00 --
Earnings (per share)
Year Ending Mar-18 1 1.30 1.30 1.30 --
Year Ending Mar-19 1 1.20 1.20 1.20 2.75
Year Ending Mar-20 1 1.70 1.70 1.70 --
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 88.58 30.95 32.74
P/E High - Last 5 Yrs. 202.74 40.70 45.73
P/E Low - Last 5 Yrs. 3.32 23.63 24.23
Beta 1.92 0.89 0.88
Price to Sales (TTM) 2.45 3.94 5.71
Price to Book (MRQ) -- 4.81 5.37
Price to Tangible Book (MRQ) -- 5.61 6.94
Price to Cash Flow (TTM) 34.23 22.91 23.32
% Owned Institutions -- 1.21 2.17

Dividends

  Company industry sector
Dividend Yield 0.10 1.56 1.50
Dividend Yield - 5 Year Avg 0.21 1.57 1.51
Dividend 5 Year Growth Rate -- 4.47 5.32
Payout Ratio(TTM) 12.73 45.35 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 18.37 2.24 7.89
Sales (TTM) vs TTM 1 Yr. Ago -7.87 4.83 5.68
Sales - 5 Yr. Growth Rate 16.63 10.08 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 202.90 16.38 19.38
EPS (TTM) vs TTM 1 Yr. Ago -57.13 -- --
EPS - 5 Yr. Growth Rate -- 9.88 10.78
Capital Spending - 5 Yr. Growth Rate 39.36 15.52 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.12 2.19
Current Ratio (MRQ) -- 2.90 2.98
LT Debt to Equity (MRQ) -- 9.88 12.19
Total Debt to Equity (MRQ) -- 13.86 16.46
Interest Coverage (TTM) 8.43 35.89 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 40.70 54.81 54.46
Gross Margin - 5 Yr. Avg. 38.62 52.15 52.22
EBITD Margin (TTM) 8.13 -- --
EBITD - 5 Yr. Avg 14.77 18.57 10.98
Operating Margin (TTM) 4.05 14.36 4.74
Operating Margin - 5 Yr. Avg. 11.77 14.52 6.41
Pre-Tax Margin (TTM) 4.12 14.82 5.58
Pre-Tax Margin - 5 Yr. Avg. 11.58 14.91 6.83
Net Profit Margin (TTM) 3.06 11.08 1.88
Net Profit Margin - 5 Yr. Avg. 9.34 11.20 3.10
Effective Tax Rate (TTM) 25.61 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. 19.36 23.42 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 11,178,110 938,104,133 846,855,612
Net Income/Employee (TTM) 342,558 110,371,237 99,619,380
Receivable Turnover (TTM) -- 5.63 5.78
Inventory Turnover (TTM) -- 2.59 3.35
Asset Turnover (TTM) -- 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.40 10.95
Return on Assets - 5 Yr. Avg. 11.52 12.91 12.32
Return on Investment (TTM) -- 14.84 14.38
Return on Investment - 5 Yr. Avg. 26.35 16.88 16.11
Return on Equity (TTM) -- 16.34 16.08
Return on Equity - 5 Yr. Avg. 27.24 17.98 17.41
  1 Year 3 Year 5 Year
Sales % -14.12 6.79 16.63
EPS (TTM) % -87.88 -50.08 --
Dividend % -58.33 -20.63 --
Note: Units in Millions of US Dollars

Performance for Marksans Pharma Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 21.88 21.40 99 25
13 Week 11.66 10.06 99 35
26 Week -8.15 -14.23 99 29
52 Week -14.00 -24.03 99 12
YTD 20.20 0.60 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.98%
# of Holders: 17
Total Shares Held: 16,291,523
3 Mo. Net Change: -536,221
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 5
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.